1. A Phase 2 Study of Oxaliplatin Combined With Continuous Infusion Topotecan for Patients With Previously Treated Ovarian Cancer. Issue 9 (1st November 2013) Authors: Stein, Stacey M.; Tiersten, Amy; Hochster, Howard S.; Blank, Stephanie V.; Pothuri, Bhavana; Curtin, John; Shapira, Ilan; Levinson, Benjamin; Ivy, Percy; Joseph, Benson; Guddati, Achuta Kumar; Muggia, Franco Journal: International journal of gynecological cancer Issue: Volume 23:Issue 9(2013) Page Start: 1577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Continuous-Infusion Topotecan and Erlotinib: A Study in Topotecan-Pretreated Ovarian Cancer Assessing Shed Collagen Epitopes as a Marker of Invasiveness. (21st February 2014) Authors: Warner, Eiran; Liebes, Leonard; Levinson, Benjamin; Downey, Andrea; Tiersten, Amy; Muggia, Franco Journal: Oncologist Issue: Volume 19:Number 3(2014) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Continuous‐Infusion Topotecan and Erlotinib: A Study in Topotecan‐Pretreated Ovarian Cancer Assessing Shed Collagen Epitopes as a Marker of Invasiveness. (21st February 2014) Authors: Warner, Eiran; Liebes, Leonard; Levinson, Benjamin; Downey, Andrea; Tiersten, Amy; Muggia, Franco Journal: Oncologist Issue: Volume 19:Number 3(2014) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. In Memoriam: Umberto Veronesi (1925–2016). (24th March 2017) Authors: Muggia, Franco Journal: Oncologist Issue: Volume 22:Number 4(2017) Page Start: 492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. In Memoriam: Umberto Veronesi (1925–2016). (April 2017) Authors: Muggia, Franco Journal: Oncologist Issue: Volume 22:Number 4(2017) Page Start: 492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Investigational agents for epithelial ovarian cancer. Issue 5 (October 2005) Authors: Muggia, Franco; Kosloff, Rebecca Journal: Expert review of anticancer therapy Issue: Volume 5:Issue 5(2005) Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications. (1st June 2014) Authors: Kudlowitz, David; Muggia, Franco Journal: Expert opinion on drug safety Issue: Volume 13:Number 6(2014:Nov.) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications. (June 2014) Authors: Kudlowitz, David; Muggia, Franco Journal: Expert opinion on drug safety Issue: Volume 13:Number 6(2014:Nov.) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Ovarian adult-type granulosa cell tumor: focusing on endocrine-based therapies. (8th October 2018) Authors: Yang, Annie D; Curtin, John; Muggia, Franco Journal: International journal of endocrine oncology Issue: Volume 5:Number 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Primary Large Cell Neuroendocrine Carcinoma of the Breast, a Case Report with an Unusual Clinical Course. Issue 3 (30th March 2015) Authors: Janosky, Maxwell; Bian, Jessica; Dhage, Shubhada; Levine, Jamie; Silverman, Joshua; Jors, Kathryn; Moy, Linda; Cangiarella, Joan; Muggia, Franco; Adams, Sylvia Journal: Breast journal Issue: Volume 21:Issue 3(2015:May/Jun.) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗